...
首页> 外文期刊>BMC Medical Genomics >BasePhasing: a highly efficient approach for preimplantation genetic haplotyping in clinical application of balanced translocation carriers
【24h】

BasePhasing: a highly efficient approach for preimplantation genetic haplotyping in clinical application of balanced translocation carriers

机译:BasePhasing:平衡易位携带者临床应用中一种高效的植入前遗传单倍型方法

获取原文
           

摘要

Preimplantation genetic testing (PGT) has already been applied in chromosomally balanced translocation carriers to improve the clinical outcome of assisted reproduction. However, traditional methods could not further distinguish embryos carrying a translocation from those with a normal karyotype prior to implantation. To solve this problem, we developed a method named “Chromosomal Phasing on Base level” (BasePhasing), which based on Infinium Asian Screening Array-24 v1.0 (ASA) and a specially phasing pipeline. Firstly, by comparing the number of single nucleotide polymorphism (SNP) loci in different minor allele frequencies (MAFs) and in 2Mbp continuous windows of ASA chip and karyomap-12 chip, we verified whether ASA could be adopted for genome-wide haplotype linkage analysis. Besides, the whole gene amplification (WGA) of 3–10 cells of GM16457 cell line was used to verify whether ASA chip could be used for testing of WGA products. Finally, two balanced translocation families were utilized to carry out BasePhasing and to validate the feasibility of its clinical application. The average number of SNP loci in each window of ASA (473.2) was twice of that of Karyomap-12 (201.2). The coincidence rate of SNP loci in genomic DNA and WGA products was about 97%. The 5.3Mbp deletion was detected positively in cell line GM16457 of both genomic DNA and WGA products, and haplotype linkage analysis was performed in genome wide successfully. In the two balanced translocation families, 18 blastocysts were analyzed, in which 8 were unbalanced and the other 10 were balanced or normal chromosomes. Two embryos were transferred back to the patients successfully, and prenatal cytogenetic analysis of amniotic fluid was performed in the second trimester. The results predicted by BasePhasing and prenatal diagnosis were totally consistent. Infinium ASA bead chip based BasePhasing pipeline shows good performance in balanced translocation carrier testing. With the characteristics of simple operation procedure and accurate results, we demonstrate that BasePhasing is one of the most suitable methods to distinguish between balanced and structurally normal chromosome embryos from translocation carriers in PGT at present.
机译:植入前基因检测(PGT)已用于染色体平衡易位载体中,以改善辅助生殖的临床效果。但是,传统方法无法在植入前进一步将携带易位的胚胎与具有正常核型的胚胎区分开。为解决此问题,我们基于Infinium亚洲筛选阵列-24 v1.0(ASA)和专门的定相流水线开发了一种名为“基本水平的染色体定相”的方法(BasePhasing)。首先,通过比较不同的次要等位基因频率(MAF)以及ASA芯片和karyomap-12芯片的2Mbp连续窗口中的单核苷酸多态性(SNP)基因座的数目,我们验证了ASA是否可以用于全基因组单倍型连锁分析。此外,使用GM16457细胞系的3-10个细胞的全基因扩增(WGA)来验证ASA芯片是否可用于测试WGA产品。最后,利用两个平衡的易位家族进行BasePhasing并验证其临床应用的可行性。 ASA的每个窗口中SNP位点的平均数(473.2)是Karyomap-12(201.2)的两倍。基因组DNA和WGA产物中SNP基因座的符合率约为97%。在基因组DNA和WGA产物的GM16457细胞系中均阳性检测到5.3Mbp缺失,并且在全基因组范围内成功进行了单倍型连锁分析。在两个平衡易位家族中,分析了18个胚泡,其中8个不平衡,另外10个平衡或正常染色体。成功将两个胚胎转移回患者体内,并在孕中期进行了羊水的产前细胞遗传学分析。 BasePhasing和产前诊断所预测的结果完全一致。基于Infinium ASA珠芯片的BasePhasing流水线在平衡易位载波测试中显示出良好的性能。具有操作过程简单和结果准确的特点,我们证明BasePhasing是目前从PGT的易位载体中区分平衡和结构正常染色体胚胎的最合适方法之一。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号